Understanding HSV-I entry glycoproteins

Reviews in Medical Virology

Volumn 17, Issue 3, 2007, Pages 205-215

  Reske, Adi ^a   Pollara, Gabriele ^a   Krummenacher, Claude ^b   Chain, Benjamin M ^a   Katz, David R ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HERPES SIMPLEX VACCINE; HETERODIMER; MEMBRANE PROTEIN; RECOMBINANT GLYCOPROTEIN B VACCINE; RECOMBINANT GLYCOPROTEIN D VACCINE; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN; VIRUS GLYCOPROTEIN B; VIRUS GLYCOPROTEIN D; VIRUS GLYCOPROTEIN H; VIRUS GLYCOPROTEIN L; VIRUS PROTEIN; GLYCOPROTEIN B, TYPE 1 HERPES SIMPLEX VIRUS; GLYCOPROTEIN GD, HERPES SIMPLEX VIRUS TYPE 1; GLYCOPROTEIN H, HERPES SIMPLEX VIRUS TYPE 1; GLYCOPROTEIN L, HUMAN HERPESVIRUS 1; VIRUS ENVELOPE PROTEIN;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTING CELL; CELL DEATH; CELL MEMBRANE; CELL SURFACE; COMPLEX FORMATION; DENDRITIC CELL; HERPES; HERPES SIMPLEX VIRUS 1; HUMAN; INNATE IMMUNITY; MACROPHAGE; MEMBRANE FUSION; NONHUMAN; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN INTERACTION; REVIEW; VIRUS CELL INTERACTION; VIRUS ENVELOPE; VIRUS IMMUNITY; CHEMISTRY; PHYSIOLOGY; VIRUS INTERNALIZATION;

HERPESVIRUS 1, HUMAN; HUMANS; VIRAL ENVELOPE PROTEINS; VIRUS INTERNALIZATION;

EID: 34249703490     PISSN: 10529276     EISSN: None     Source Type: Journal    
DOI: 10.1002/rmv.531     Document Type: Review

References (104)

1. Witteis M, Spear PG. Penetration of cells by herpes simplex virus does not require a low pH-dependent endocytic pathway. Virus Res 1991; 18(2-3): 271-290.
2. Koyama AH, Uchida T. The mode of entry of herpes simplex virus type 1 into Vero cells. Microbiol Immunol 1987; 31(2): 123-130.
3. Nicola A, McEvoy A, Straus S. Roles for endocytosis and low pH in herpes simplex virus entry into HeLa and Chinese hamster ovary cells. J Virol 2003; 77(9): 5324-5332.
4. Nicola A, Hou J, Major E, Straus S. herpes simplex virus type 1 enters human epidermal keratinocytes, but not neurons, via a pH-dependent endocytic pathway. J Virol 2005; 79(12): 7609-7616.
5. Milne R, Nicola A, Whitbeck J, Eisenberg R, Cohen G. Glycoprotein D receptor-dependent, low-pH-independent endocytic entry of herpes simplex virus type 1. J Virol 2005; 79(11): 6655-6663.
6. Nicola A, Straus S. Cellular and viral requirements for rapid endocytic entry of herpes simplex virus. J Virol 2004; 78(14): 7508-7517.
7. Campadelli-Fiume G, Cocchi F, Menotti L, Lopez M. The novel receptors that mediate the entry of herpes simplex viruses and animal alphaherpesviruses into cells. Rev Med Virol 2000; 10(5): 305-319.
8. Spear P. Herpes simplex virus: receptors and ligands for cell entry. Cell Microbiol 2004; 6(5): 401-110.
9. Shieh M, WuDunn D, Montgomery R, Esko J, Spear P. Cell surface receptors for herpes simplex virus are heparan sulfate proteoglycans. J Cell Biol 1992; 116(5): 1273-1281.
10. Herold B, Visalli R, Susmarski N, Brandt C, Spear P. Glycoprotein C-independent binding of herpes simplex virus to cells requires cell surface heparan sulphate and glycoprotein B. J Gen Virol 1994; 75(6): 1211-1222.
11. Laquerre S, Argnani R, Anderson D, Zucchini S, Manservigi R, Glorioso J. Heparan sulfate proteoglycan binding by herpes simplex virus type 1 Glycoproteins B and C, which differ in their contributions to virus attachment, penetration, and cell-to-cell spread. J Virol 1998; 72(7): 6119-6130.
12. Bender F, Whitbeck J, Lou H, Cohen G, Eisenberg R. Herpes simplex virus glycoprotein B binds to cell surfaces independently of heparan sulfate and blocks virus entry. J Virol 2005; 79(18): 11588-11597.
13. Montgomery R, Warner M, Lum B, Spear P. Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell 1996; 87(3): 427-436.
14. Whitbeck J, Peng C, Lou H, et al. Glycoprotein D of herpes simplex virus (HSV) binds directly to HVEM, a member of the tumor necrosis factor receptor superfamily and a mediator of HSV entry. J Virol 1997; 71(8): 6083-6093.
15. Geraghty R, Krummenacher C, Cohen G, Eisenberg R, Spear P. Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor. Science 1998; 280(5369): 1618-1620.
16. Shukla D, Liu J, Blaiklock P, et al. A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. Cell 1999; 99(1): 13-22.
17. Richart S, Simpson S, Krummenacher C, et al. Entry of herpes simplex virus type 1 into primary sensory neurons in vitro is mediated by nectin-1/HveC. J Virol 2003; 77(5): 3307-3311.
18. Tiwari V, Clement C, Xu D, Valyi-Nagy T, Yue BYJT, Shukla D. Role for 3-O-sulfated heparan sulfate as the receptor for herpes simplex virus type 1 entry into primary human corneal fibroblasts. J Virol 2006; 80(18): 8970-8980.
19. Tiwari V, Clement C, Scanlan P, Kowlessur D, Yue B, Shukla D. A role for herpesvirus entry mediator as the receptor for herpes simplex virus 1 entry into primary human trabecular meshwork cells. J Virol 2005; 79(20): 13173-13179.
20. Krummenacher C, Baribaud F, Ponce de Leon M, et al. Comparative usage of herpesvirus entry mediator A and nectin-1 by laboratory strains and clinical isolates of herpes simplex virus. Virology 2004; 322(2): 286-299.
21. Watson RJ, Vande Woude GF. DNA sequence of an immediate-early gene (IEmRNA-5) of herpes simplex virus type I. Nucleic Acids Res 1982; 10(3): 979-991.
22. Carfi A, Willis S, Whitbeck J, et al. Herpes simplex virus glycoprotein D bound to the human receptor HveA. Mol Cell 2001; 8(1): 169-179.
23. Connolly S, Landsburg D, Carfi A, Wiley D, Cohen G, Eisenberg R. Structure-based mutagenesis of herpes simplex virus glycoprotein D defines three critical regions at the gD-HveA/HVEM binding interface. J Virol 2003; 77(14): 8127-8140.
24. Connolly S, Landsburg D, Carfi A, et al. Potential nectin-1 binding site on herpes simplex virus glycoprotein D. J Virol 2005; 79(2): 1282-1295.
25. Krummenacher C, Supekar VM, Whitbeck JC, et al. Structure of unliganded HSV gD reveals a mechanism for receptor-mediated activation of virus entry. EMBO 2005; 24(23): 4144-4153.
26. Whitbeck J, Muggeridge M, Rux A, et al. The major neutralizing antigenic site on herpes simplex virus glycoprotein D overlaps a receptor-binding domain. J Virol 1999; 73(12): 9879-9890.
27. Manoj S, Jogger C, Myscofski D, Yoon M, Spear P. Inaugural article: mutations in herpes simplex virus glycoprotein D that prevent cell entry via nectins and alter cell tropism. PNAS 2004; 101(34): 12414-12421.
28. Chiang HY, Cohen GH, Eisenberg RJ. Identification of functional regions of herpes simplex virus glycoprotein gD by using linker-insertion mutagenesis. J Virol 1994; 68(4): 2529-2543.
29. Cairns T, Milne R, Ponce-de-Leon M, et al. Structure-function analysis of herpes simplex virus type 1 gD and gH-gL: clues from gDgH chimeras. J Virol 2003; 77(12): 6731-6742.
30. Cocchi F, Fusco D, Menotti L, et al. The soluble ecto-domain of herpes simplex virus gD contains a membrane-proximal pro-fusion domain and suffices to mediate virus entry. PNAS 2004; 101(19): 7445-7450.
31. Cai WZ, Person S, DebRoy C, Gu BH. Functional regions and structural features of the gB glycoprotein of herpes simplex virus type 1. An analysis of linker insertion mutants. J Mol Biol 1988; 201(3): 575-588.
32. Zago A, Jogger C, Spear P. Use of herpes simplex virus and Pseudorabies virus chimeric glycoprotein D molecules to identify regions critical for membrane fusion. PNAS 2004; 101(50): 17498-17503.
33. Wilson IA, Skehel JJ, Wiley DC. Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution. Nature 1981; 289(5796): 366-373.
34. Bullough P, Hughson F, Skehel J, Wiley D. Structure of influenza haemagglutinin at the pH of membrane fusion. Nature 1994; 371(6492): 37-43.
35. Yin H, Wen X, Paterson R, Lamb R, Jardetzky T. Structure of the parainfluenza virus 5 F protein in its metastable, prefusion conformation. Nature 2006; 439(7072): 38-44.
36. Fass D, Harrison SC, Kim PS. Retrovirus envelope domain at 1.7 angstrom resolution. Nat Struct Biol 2006; 3(5): 465-469.
37. Weissenhorn W, Carfi A, Lee K, Skehel J, Wiley D. Crystal structure of the ebola virus membrane fusion subunit, GP2, from the envelope glycoprotein ectodomain. Mol Cell 1998; 2(5): 605-616.
38. Xu Y, Lou Z, Liu Y, et al. Crystal structure of severe acute respiratory syndrome Coronavirus spike protein fusion core. J Biol Chem 2004; 279(47): 49414-49419.
39. Colman P, Lawrence M. The structural biology of type I viral membrane fusion. Nat Rev Mol Cell Biol 2003; 4(4): 309-319.
40. Jardetzky T, Lamb R. Virology A class act. Nature 2004; 427(6972): 307-308.
41. Schibli DJ, Weissenhorn W. Class I and class II viral fusion protein structures reveal similar principles in membrane fusion. Mol Membr Biol 2004; 21(6): 361-371.
42. Rey F, Heinz F, Mandl C, Kunz C, Harrison S. The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution. Nature 1995; 375(6529): 291-298.
43. Modis Y, Ogata S, Clements D, Harrison S. A ligand-binding pocket in the dengue virus envelope glycoprotein. PNAS 2003; 100(12): 6986-6991.
44. Lescar J, Roussel A, Wien M, et al. The fusion glycoprotein shell of semliki forest virus: an icosahedral assembly primed for fusogenic activation at endosomal pH. Cell 2001; 105(1): 137-148.
45. Kielian M. Class II virus membrane fusion proteins. Virology 2006; 344(1): 38-47.
46. Gompels U, Minson A. The properties and sequence of glycoprotein H of herpes simplex virus type 1. Virology 1986; 153(2): 230-247.
47. Forrester A, Farrell H, Wilkinson G, Kaye J, Davis-Poynter N, Minson T. Construction and properties of a mutant of herpes simplex virus type 1 with glycoprotein H coding sequences deleted. J Virol 1992; 66(1): 341-348.
48. Pereira L. Function of glycoprotein B homologues of the family herpesviridae. Infect Agents Dis 1994; 3(1): 9-28.
49. Gianni T, Menotti L, Campadelli-Fiume G. A heptad repeat in herpes simplex virus 1 gH, located downstream of the {α}-Helix with attributes of a fusion peptide, is critical for virus entry and fusion. J Virol 2005; 79(11): 7042-7049.
50. Gianni T, Martelli P, Casadio R, Campadelli-Fiume G. The ectodomain of herpes simplex virus glycoprotein H contains a membrane {α}-Helix with attributes of an internal fusion peptide, positionally conserved in the herpesviridae family. J Virol 2005; 79(5): 2931-2940.
51. Peng T, Ponce de Leon M, Novorny M, et al. Structural and antigenic analysis of a truncated form of the herpes simplex virus glycoprotein gH-gL complex. J Virol 1998; 72(7): 6092-6103.
52. Dubin G, Jiang H. Expression of herpes simplex virus type 1 glycoprotein L (gL) in transfected mammalian cells: evidence that gL is not independently anchored to cell membranes. J Virol 1995; 69(7): 4564-4568.
53. Hutchinson L, Brown H, Wargent V, et al. A novel herpes simplex virus glycoprotein, gL, forms a complex with glycoprotein H (gH) and affects normal folding and surface expression of gH. J Virol 1992; 66(4): 2240-2250.
54. Roop D, Hutchinson L, Johnson D. A mutant herpes simplex virus type 1 unable to express glycoprotein L cannot enter cells, and its particles lack glycoprotein H. J Virol 1993; 67(4): 2285-2297.
55. Bzik DJ, Fox BA, DeLuca NA, Person S. Nucleotide sequence specifying the glycoprotein gene, gB, of herpes simplex virus type 1. Virology 1984; 133(2): 301-314.
56. Pellett PE, Kousoulas KG, Pereira L, Roizman B. Anatomy of the herpes simplex virus 1 strain F glycoprotein B gene: primary sequence and predicted protein structure of the wild type and of monoclonal antibody-resistant mutants. J Virol 1985; 53 (1): 243-253.
57. Rasile L, Ghosh K, Raviprakash K, Ghosh HP. Effects of deletions in the carboxy-terminal hydrophobic region of herpes simplex virus glycoprotein gB on intracellular transport and membrane anchoring. J Virol 1993; 67(8): 4856-4866.
58. Heldwein E, Lou H, Bender F, Cohen G, Eisenberg R, Harrison S. Crystal structure of glycoprotein B from herpes simplex virus 1. Science 2006; 313(5784): 217-220.
59. Highlander SL, Cai WH, Person S, Levine M, Glorioso JC. Monoclonal antibodies define a domain on herpes simplex virus glycoprotein B involved in virus penetration. J Virol 1988; 62(6): 1881-1889.
60. Roche S, Bressanelli S, Rey F, Gaudin Y. Crystal structure of the low-pH form of the vesicular stomatitis virus glycoprotein G. Science 2006; 313(5784): 187-191.
61. Cohen GH, Ponce de Leon M, Nichols C. Isolation of a herpes simplex virus-specific antigenic fraction which stimulates the production of neutralizing antibody. J Virol 1972; 10(5): 1021-1030.
62. Balachandran N, Bacchetti S, Rawls WE. Protection against lethal challenge of BALB/c mice by passive transfer of monoclonal antibodies to five glycoproteins of herpes simplex virus type 2. Infect Immun 1982; 37(3): 1132-1137.
63. Chan W, Lukig M, Liew F. Helper T cells induced by an immunopurified herpes simplex virus type I (HSV-I) 115 kilodalton glycoprotein (gB) protect mice against HSV-I infection. J Exp Med 1985; 162(4): 1304-1318.
64. Eisenberg RJ, Cerini CP, Heilman CJ, et al. Synthetic glycoprotein D-related peptides protect mice against herpes simplex virus challenge. J Virol 1985; 56(3): 1014-1017.
65. Peng T, Ponce-de-Leon M, Jiang H, et al. The gH-gL complex of herpes simplex virus (HSV) stimulates neutralizing antibody and protects mice against HSV type 1áChallenge. J Virol 1998; 72(1): 65-72.
66. Browne H, Baxter V, Minson T. Analysis of protective immune responses to the glycoprotein H-glycoprotein L complex of herpes simplex virus type 1. J Gen Virol 1993; 74(Pt 12): 2813-2817.
67. Zarling J, Moran P, Burke R, Pachi C, Berman P, Lasky L. Human cytotoxic T cell clones directed against herpes simplex virus- infected cells. IV. Recognition and activation by cloned glycoproteins gB and gD. J Immunol 1986; 136(12): 4669-4673.
68. Blacklaws BA, Nash AA, Darby G. Specificity of the immune response of mice to herpes simplex virus glycoproteins B and D constitutively expressed on L cell lines. J Gen Virol 1987; 68(Pt 4): 1103-1114.
69. + T lymphocytes from infected mice. Characterization of T cell clones. J Immunol 1990; 145(2): 702-710.
70. Nugent CT, Wolcott RM, Chervenak R, Jennings SR. Analysis of the cytolytic T-lymphocyte response to herpes simplex virus type 1 glycoprotein B during primary and secondary infection. J Virol 1994; 68(11): 7644-7648.
71. Mikloska Z, Cunningham A. Herpes simplex virus type 1 glycoproteins gB, gC and gD are major targets for CD4 T-lymphocyte cytotoxicity in HLA-DR expressing human epidermal keratinocytes. J Gen Virol 1998; 79(2): 353-361.
72. Medici M, Sciortino M, Perri D, et al. Protection by herpes simplex virus glycoprotein D against Fas-mediated apoptosis: role of nuclear factor {κ}. J Biol Chem 2003; 278(38): 36059-36067.
73. Rinaldo CR Jr., Richter BS, Black PH, Callery R, Chess L, Hirsch MS. Replication of herpes simplex virus and cytomegalovirus in human leukocytes. J Immunol 1978; 120 (1): 130-136.
74. Posavad CM, Newton JJ, Rosenthal KL. Infection and inhibition of human cytotoxic T lymphocytes by herpes simplex virus. J Virol 1994; 68(6): 4072-4074.
75. Raftery M, Behrens C, Muller A, Krammer P, Walczak H, Schonrich G. Herpes simplex virus type 1 infection of activated cytotoxic T cells: induction of fratricide as a mechanism of viral immune evasion. J Exp Med 1999; 190(8): 1103-1114.
76. Sloan D, Han J, Sandifer T, et al. Inhibition of TCR signaling by herpes simplex virus. J Immunol 2006; 176(3): 1825-1833.
77. La S, Kim J, Kwon BS, Kwon B. Herpes simplex virus type 1 glycoprotein D inhibits T-cell proliferation. Mol Cells 2002; 14(3): 389-403.
78. Stanberry LR. Clinical trials of prophylactic and therapeutic herpes simplex virus vaccines. Herpes 2004; 11(Suppl. 3): 161A-169A.
79. Koelle DM. Vaccines for herpes simplex virus infections. Curr Opin Investig Drugs 2006; 7(2): 136-141.
80. Meignier B, Longnecker R, Roizman B. In vivo behavior of genetically engineered herpes simplex viruses R7017 and R7020: construction and evaluation in rodents. J Infect Dis 1988; 158(3): 602-614.
81. Whitley RJ. Prospects for vaccination against herpes simplex virus. Pediatr Ann 1993; 22(12): 729-732.
82. Ghiasi H, Nesburn A, Wechsler S. Vaccination with a cocktail of seven recombinantly expressed HSV-1 glycoproteins protects against ocular HSV-1 challenge more efficiently than vaccination with any individual glycoprotein. Vaccine 1996; 14(2): 107-112.
83. Manservigi R, Boero A, Argnani R, et al. Immunotherapeutic activity of a recombinant combined gB-gD-gE vaccine against recurrent HSV-2 infections in a guinea pig model. Vaccine 2005; 23(7): 865-872.
84. Hirano M, Nakamura S, Mitsunaga F, et al. Efficacy of a B virus gD DNA vaccine for induction of humoral and cellular immune responses in Japanese macaques. Vaccine 2002; 20(19-20): 2523-2532.
85. Zhu X, Ramos TV, Gras-Masse H, Kaplan BE, Ben-Mohamed L. Lipopeptide epitopes extended by an nepsilon-palmitoyl-lysine moiety increase uptake and maturation of dendritic cells through a toll-like receptor-2 pathway and trigger a Th1-dependent protective immunity. Eur J Immunol 2004; 34(11): 3102-3114.
86. Osorio Y, Sharifi BG, Perng G, Ghiasi NS, Ghiasi H. The role of T(H)1 and T(H)2 cytokines in HSV-1-induced corneal scarring. Ocul Immunol Inflamm 2002; 10(2): 105-116.
87. Corey L, Langenberg A, Ashley R, et al. Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. JAMA 1999; 282(4): 331-340.
88. Stanberry L, Spruance S, Cunningham A, et al. Glycoprotein-D- adjuvant vaccine to prevent genital herpes. N Engl J Med 2002; 347(21): 1652-1661.
89. Hendrzak JA, Morahan PS. The role of macrophages and macrophage cytokines in host resistance to herpes simplex virus. Immunol Ser 1994; 60: 601-617.
90. Hoves S, Niller H, Krause S, et al. Decreased T cell stimulatory capacity of monocyte-derived human macrophages following herpes simplex virus type 1 Infection. Scand J Immunol 2001; 54(1-2): 93-99.
91. Malmgaard L, Melchjorsen J, Bowie A, Mogensen S, Paludan S. Viral activation of macrophages through TLR-dependent and -independent pathways. J Immunol 2004; 173(11): 6890-6898.
92. Salio M, Cella M, Suter M, Lanzavecchia A. Inhibition of dendritic cell maturation by herpes simplex virus. Eur J Immunol 1999; 29(10): 3245-3253.
93. Kruse M, Rosorius O, Kratzer F, et al. Mature dendritic cells infected with herpes simplex virus type 1 exhibit inhibited T-cell stimulatory capacity. J Virol 2000; 74(15): 7127-7136.
94. Pollara G, Speidel K, Samady L, et al. Herpes simplex virus infection of dendritic cells: balance among activation, inhibition, and immunity. J Infect Dis 2002; 187: 165-178.
95. Pollara G, Jones M, Handley M, et al. Herpes simplex virus type-1-induced activation of myeloid dendritic cells: the roles of virus cell interaction and paracrine type I IFN secretion. J Immunol 2004; 173(6): 4108-4119.
96. Kassim S, Rajasagi N, Zhao X, Chervenak R, Jennings S. In vivo ablation of CD11c-positive dendritic cells increases susceptibility to herpes simplex virus type 1 infection and diminishes NK and T-cell responses. J Virol 2006; 80(8): 3985-3993.
97. Marsters S, Ayres T, Skubatch M, Gray C, Rothe M, Ashkenazi A. Herpesvirus entry mediator, a member of the tumor necrosis factor receptor (TNFR) family, interacts with members of the TNFR-associated factor family and activates the transcription factors NF-kappa B and AP-1. J Biol Chem 1997; 272(22): 14029-14032.
98. Tamada K, Shimozaki K, Chapoval A, et al. LIGHT, a TNF-like molecule, costimulates T cell proliferation and is required for dendritic cell-mediated allogeneic T cell response. J Immunol 2000; 164(8): 4105-4110.
99. Hikichi Y, Matsui H, Tsuji I, et al. LIGHT, a member of the TNF superfamily, induces morphological changes and delays proliferation in the human rhabdomyosarcoma cell line RD. Biochem Biophys Rese Commun 2001; 289(3): 670-677.
100. Pollara G, Katz D, Chain B. LIGHTing up dendritic cell activation: immune regulation and viral exploitation. J Cell Physiol 2005; 205(2): 161-162.
101. Ankel H, Westra D, Welling-Wester S, Lebon P. Induction of interferon-[alpha] by glycoprotein D of herpes simplex virus: a possible role of chemokine receptors. Virology 1998; 251(2): 317-326.
102. Mogensen T, Paludan S. Molecular pathways in virus-induced cytokine production. Microbiol Mol Biol Rev 2001; 65(1): 131-150.
103. Melchjorsen J, Siren J, Julkunen I, Paludan S, Matikainen S. Induction of cytokine expression by herpes simplex virus in human monocyte-derived macrophages and dendritic cells is dependent on virus replication and is counteracted by ICP27 targeting NF-{κ}B and IRF-3. J Gen Virol 2006; 87(5): 1099-1108.
104. Luft T, Luetjens P, Hochrein H, et al. IFN-{α} enhances CD40 ligand-mediated activation of immature monocyte-derived dendritic cells. Int Immunol 2002; 14(4): 367-380.